<?xml version="1.0"?>
<?xml-stylesheet type="text/xsl" href="billres.xsl"?>
<!DOCTYPE bill PUBLIC "-//US Congress//DTDs/bill.dtd//EN" "bill.dtd">
<bill bill-stage="Introduced-in-House" dms-id="H609648A9F5944DEEA0E31D85F0C9218C" public-private="public" bill-type="olc"> 
<metadata xmlns:dc="http://purl.org/dc/elements/1.1/">
<dublinCore>
<dc:title>109 HR 3937 IH: To include dehydroepiandrosterone as an anabolic steroid.</dc:title>
<dc:publisher>U.S. House of Representatives</dc:publisher>
<dc:date>2005-09-28</dc:date>
<dc:format>text/xml</dc:format>
<dc:language>EN</dc:language>
<dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
</dublinCore>
</metadata>
<form> 
<distribution-code display="yes">I</distribution-code> 
<congress>109th CONGRESS</congress>
<session>1st Session</session>
<legis-num>H. R. 3937</legis-num> 
<current-chamber>IN THE HOUSE OF REPRESENTATIVES</current-chamber> 
<action> 
<action-date date="20050928">September 28, 2005</action-date> 
<action-desc><sponsor name-id="S001149">Mr. Sweeney</sponsor> introduced the following bill; which was referred to the <committee-name committee-id="HIF00">Committee on Energy and Commerce</committee-name>, and in addition to the Committee on the <committee-name committee-id="HJU00">Judiciary</committee-name>, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned</action-desc>
</action> 
<legis-type>A BILL</legis-type> 
<official-title>To include dehydroepiandrosterone as an anabolic steroid.</official-title> 
</form> 
<legis-body id="H8972BF188DE4496494B403533C4E0236" style="OLC"> 
<section section-type="section-one" id="H674AAB9ECF054663A51FDC426600CA6B" display-inline="no-display-inline"><enum>1.</enum><header>Inclusion of dehydroepiandrosterone</header><text display-inline="no-display-inline">Section 102(41)(A) of the <act-name parsable-cite="CSA">Controlled Substances Act</act-name> (<external-xref legal-doc="usc" parsable-cite="usc/21/802">21 U.S.C. 802(41)(A)</external-xref>) is amended—</text> 
<paragraph id="H4969BAC2C5DE4BF1BD69FACBBA920000"><enum>(1)</enum><text>in the matter preceding clause (i), by striking <quote>corticosteroids, and dehydroepiandrosterone</quote> and inserting <quote>and corticosteroids</quote>;</text></paragraph> 
<paragraph id="HD11D1EF44EB040CC8C59A8D920F8A75D"><enum>(2)</enum><text>by redesignating clauses (x) through (xlx) as clauses (xi) through (xlxi), respectively; and</text></paragraph> 
<paragraph id="H6B1488AFDA8D40B4A05E27316EC9BC70"><enum>(3)</enum><text>by inserting after clause (ix) the following:</text> 
<quoted-block id="H6443710E9C0F4EF490369061BEF0900"> 
<clause indent="paragraph" id="H169FD557D75240C2A037B59B9D3B427F"><enum>(x)</enum><text>dehydroepiandrosterone (androst-5-en-3β-ol-17-one);</text></clause><after-quoted-block>.</after-quoted-block></quoted-block></paragraph></section> 
</legis-body> 
</bill> 

